Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 8
2018 15
2019 18
2020 26
2021 28
2022 26
2023 39
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events.
Gragnano F, Cao D, Pirondini L, Franzone A, Kim HS, von Scheidt M, Pettersen AR, Zhao Q, Woodward M, Chiarito M, McFadden EP, Park KW, Kastrati A, Seljeflot I, Zhu Y, Windecker S, Kang J, Schunkert H, Arnesen H, Bhatt DL, Steg PG, Calabrò P, Pocock S, Mehran R, Valgimigli M; PANTHER Collaboration. Gragnano F, et al. J Am Coll Cardiol. 2023 Jul 11;82(2):89-105. doi: 10.1016/j.jacc.2023.04.051. J Am Coll Cardiol. 2023. PMID: 37407118
P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions.
Gragnano F, Mehran R, Branca M, Franzone A, Baber U, Jang Y, Kimura T, Hahn JY, Zhao Q, Windecker S, Gibson CM, Kim BK, Watanabe H, Song YB, Zhu Y, Vranckx P, Mehta S, Hong SJ, Ando K, Gwon HC, Calabrò P, Serruys PW, Dangas GD, McFadden EP, Angiolillo DJ, Heg D, Valgimigli M; Single Versus Dual Antiplatelet Therapy (Sidney-2) Collaboration. Gragnano F, et al. J Am Coll Cardiol. 2023 Feb 14;81(6):537-552. doi: 10.1016/j.jacc.2022.11.041. J Am Coll Cardiol. 2023. PMID: 36754514 Free article.
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry.
Paolisso P, Bergamaschi L, Gragnano F, Gallinoro E, Cesaro A, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Esposito G, Morici N, Andrea OJ, Casella G, Mauro C, Vassilev D, Galie N, Santulli G, Marfella R, Calabrò P, Pizzi C, Barbato E. Paolisso P, et al. Among authors: gragnano f. Pharmacol Res. 2023 Jan;187:106597. doi: 10.1016/j.phrs.2022.106597. Epub 2022 Dec 5. Pharmacol Res. 2023. PMID: 36470546 Free PMC article.
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry.
Paolisso P, Bergamaschi L, Santulli G, Gallinoro E, Cesaro A, Gragnano F, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Casella G, Mauro C, Vassilev D, Marfella R, Calabrò P, Barbato E, Pizzi C. Paolisso P, et al. Among authors: gragnano f. Cardiovasc Diabetol. 2022 May 15;21(1):77. doi: 10.1186/s12933-022-01506-8. Cardiovasc Diabetol. 2022. PMID: 35570280 Free PMC article.
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.
Valgimigli M, Gragnano F, Branca M, Franzone A, Baber U, Jang Y, Kimura T, Hahn JY, Zhao Q, Windecker S, Gibson CM, Kim BK, Watanabe H, Song YB, Zhu Y, Vranckx P, Mehta S, Hong SJ, Ando K, Gwon HC, Serruys PW, Dangas GD, McFadden EP, Angiolillo DJ, Heg D, Jüni P, Mehran R. Valgimigli M, et al. Among authors: gragnano f. BMJ. 2021 Jun 16;373:n1332. doi: 10.1136/bmj.n1332. BMJ. 2021. PMID: 34135011 Free PMC article.
Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go.
Vergara A, De Felice M, Cesaro A, Gragnano F, Pariggiano I, Golia E, De Pasquale A, Blasi E, Fimiani F, Monda E, Limongelli G, Calabrò P. Vergara A, et al. Among authors: gragnano f. Angiology. 2023 Sep 12:33197231201929. doi: 10.1177/00033197231201929. Online ahead of print. Angiology. 2023. PMID: 37699402 Review.
[The COMPASS study].
Calabrò P, Gragnano F, Visconti LO. Calabrò P, et al. Among authors: gragnano f. G Ital Cardiol (Rome). 2018 Jan;19(1):1-7. doi: 10.1714/2852.28773. G Ital Cardiol (Rome). 2018. PMID: 29451504 Clinical Trial. Italian. No abstract available.
Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options.
Cesaro A, De Michele G, Fimiani F, Acerbo V, Scherillo G, Signore G, Rotolo FP, Scialla F, Raucci G, Panico D, Gragnano F, Moscarella E, Scudiero O, Mennitti C, Calabrò P. Cesaro A, et al. Among authors: gragnano f. Front Cardiovasc Med. 2023 Jul 27;10:1187735. doi: 10.3389/fcvm.2023.1187735. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37576108 Free PMC article. Review.
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives.
Nevola R, Villani A, Imbriani S, Alfano M, Criscuolo L, Beccia D, Ruocco R, Femine AD, Gragnano F, Cozzolino D, Marfella R, Adinolfi LE, Sasso FC, Rinaldi L. Nevola R, et al. Among authors: gragnano f. Front Biosci (Landmark Ed). 2023 May 25;28(5):103. doi: 10.31083/j.fbl2805103. Front Biosci (Landmark Ed). 2023. PMID: 37258483 Free article. Review.
149 results